Hepatology
Patient Information
Can hepatitis B and C be eliminated?
News
Ocaliva approved for primary biliary cholangitis
News
HCV regimen found safe, effective in patients with severe renal disease
A 12-week regimen of ombitasvir, paritaprevir, ritonavir, and dasabuvir achieved sustained viral response for 90% of patients with genotype 1...
News
Chronic HCV boosts hospitalization risk, not just for liver
Patients with chronic hepatitis C infection have significantly greater risk of hospitalization for a range of health issues.
News
Hepatitis A and B combo vaccinations remain effective after 15 years
Young adults who received a combined hepatitis A and B vaccination at age 12-15 years maintained immunity after 15 years, making a booster shot...
News
Hepatitis B vaccine in infancy provides long-term protection into adolescence
Pediatric doses of hepatitis B vaccine can provide long-term protection against hepatitis B up to 15-16 years.
News
Initiative dramatically raises HCV screening, treatment
A hepatitis C awareness initiative dramatically raised the rate of HCV screening and treatment in a large American Indian population – the ethnic...
News
Hepatocellular carcinoma risk quantified in PBC patients
News
FDA publishes draft guidance for developing HCV antivirals
The U.S. Food and Drug Administration has issued revised draft guidance intended to foster the development of direct-acting antiviral drugs to...
Conference Coverage
Male HPV vaccination rates soar with intensive QI project
A 3-year quality improvement (QI) measure succeeded in delivering the full human papillomavirus series to more than four out of five eligible boys...
News
Hepatitis Outlook: April 2016
Quantitative maternal surface antigen predicts hepatitis B virus infection in infants as well as maternal viral load does. Read about this and...